| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004583 | American Journal of Ophthalmology | 2007 | 6 Pages |
Abstract
One-year suppression therapy with oral valacyclovir (500 mg tablet daily) was shown to be as effective and as well tolerated as acyclovir (400 mg tablet twice daily) in reducing the rate of recurrent ocular HSV disease.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Elisabetta Miserocchi, Giulio Modorati, Laura Galli, Paolo Rama,